ArkBio's Ziresovir gains US FDA Phase II clinical trial approval

Rigel's VEPPANU (vepdegestrant) available for patients with ER+/HER2-, ESR1-mutated advanced or metastatic breast cancer

Innorna Nominated for 2026 Prix Galien USA Best Startup Award

Aurisco Pharmaceutical reports successful US FDA inspection

PTC to acquire BLA-stage ST-920 Fabry disease programme

Graviton BioScience's Investigational New Drug (IND) application for GV101 cleared for Friedreich's ataxia treatment

Galvanize Therapeutics' new Aliya EX System completes first commercial procedures

EIT Pharma's lonafarnib New Drug Application accepted for review by US FDA for chronic hepatitis D treatment

Lupin's Sodium Zirconium Cyclosilicate for Oral Suspension approved by US FDA

Labcorp receives FDA approval for melanoma companion diagnostic

Sobi partners with Innate Pharma to advance lacutamab in T-cell lymphoma

Oculis signs agreement to acquire Privosegtor from Accure Therapeutics

Biophytis receives Brazilian approval for Phase 2 obesity trial of BIO101

ImmuPharma selects Kymos Group as bioanalytical partner for Kapiglucagon

BioInvent receives FDA Fast Track designation for BI-1808 in ovarian cancer